Drawing for 3NT MEDICAL

USPTO serial 86686850

3NT MEDICAL

Reviewed by CopyMark Law Group

Reg. 5211598Status 701Renewal
Filing date
Status date
Registration date
May 30, 2017
Examiner
HELLMAN, ELI J
Law office
TMO LAW OFFICE 112

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with 3NT MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robyn S. Lederman

Robyn S. Lederman Brooks Kushman P C1000 Town Ctr Fl 22Southfield, MI 48075-1183UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010MEDICAL DEVICES AND INSTRUMENTS FOR USE IN THE EXAMINATION, TREATMENT, AND SURGERY OF THE EAR, NOSE, AND THROAT, namely, OTOSCOPES, NASOPHARYNGOSCOPES, [ BRONCHOSCOPES, ESOPHAGOSCOPES, ] LARYNGOSCOPES, DILATATION DEVICES, [ DRUG DELIVERY DEVICES, ] NASAL IRRIGATORS, [ SINUS ULTRASOUNDS, LASERS ] ; SURGICAL DEVICES AND INSTRUMENTS FOR USE IN THE EXAMINATION, TREATMENT, AND SURGERY OF THE EAR, NOSE AND THROAT; MEDICAL DEVICES AND INSTRUMENTS FOR DIAGNOSING, MONITORING, OR TREATING EAR, NOSE, AND THROAT CONDITIONS AND DISEASES, namely, OTOSCOPES, NASOPHARYNGOSCOPES, [ BRONCHOSCOPES, ESOPHAGOSCOPES, ] LARYNGOSCOPES, DILATATION DEVICES, [ DRUG DELIVERY DEVICES, ] NASAL IRRIGATORS, [ SINUS ULTRASOUNDS, LASERS, ] SURGICAL DEVICES AND INSTRUMENTS FOR DIAGNOSING, MONITORING, OR TREATING EAR, NOSE, AND THROAT CONDITIONS AND DISEASES; MEDICAL ENDOSCOPES USED IN APPLICATIONS FOR THE EAR, NOSE, AND THROATACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 3, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 3, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Dec 28, 2022EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Dec 27, 2022PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Dec 23, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 1, 2022ES8RTEAS SECTION 8 RECEIVED—
May 30, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 30, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 25, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 6, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 6, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 6, 2016CNSISUSPENSION INQUIRY WRITTEN—
May 5, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 5, 2016GNSLLETTER OF SUSPENSION E-MAILED—
May 5, 2016CNSLSUSPENSION LETTER WRITTEN—
May 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 5, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 28, 2016ALIEASSIGNED TO LIE—
Apr 16, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2015DOCKASSIGNED TO EXAMINER—
Jul 14, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jul 13, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance